Gemtesa 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FEZMW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,747
Award facts
- Contract value 100% obligated
- $1,747.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,747.33 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Gemtesa is a prescription medication used to treat overactive bladder symptoms, representing the type of pharmaceutical product routinely procured through federal medical supply channels to support military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's consistent performance across competitively awarded contracts demonstrates its capability to fulfill federal medical procurement requirements across diverse product categories and transaction values.
Quick answers
Who was awarded contract SPE2DB25FEZMW?
SPE2DB25FEZMW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FEZMW worth?
The government has obligated $1,747 on SPE2DB25FEZMW.
Is contract SPE2DB25FEZMW an order under another contract?
Yes. SPE2DB25FEZMW is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FEZMW competed?
The extent of competition for SPE2DB25FEZMW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award